First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium

Research output: Contribution to journalArticlepeer-review

73 Citations (Scopus)
Original languageEnglish
Pages (from-to)861-867
Number of pages7
JournalEuropean Urology
Volume76
Issue number6
DOIs
Publication statusPublished - Dec 2019
Externally publishedYes

ASJC Scopus Subject Areas

  • Urology

Keywords

  • Checkpoint inhibitors
  • Combinations
  • First line
  • Immuno-oncology
  • International Metastatic Renal-cell Carcinoma Database Consortium
  • Metastatic
  • Programmed-Death 1 inhibitor
  • Renal-cell carcinoma
  • Survival

Fingerprint

Dive into the research topics of 'First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium'. Together they form a unique fingerprint.

Cite this